We want to share the letter that FAST sent to Anthem regarding their Spinraza medical policy. Below is a copy of the letter we emailed to Joseph Swedish, CEO of Anthem, yesterday. In addition, we would like to thank Ben Fidler & Xconomy (article regarding this issue here: http://www.xconomy.com/…/anthem-caps-coverage-of-biogen-sp…/) for their outreach to Anthem and their outstanding coverage of the challenges that the SMA community faces as we work to access the first treatment for SMA.
Please stay tuned for updates on this situation. If the Anthem policy is not amended soon, FAST will share a clear Call to Action that you all can help with.